medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2021; 19 (1)

Dermatology, Genetics, and Fictional Characters: Inspiring “Abnormality”

Trejo-Acuña JR, García-Alonso MJ, Torres-Victoria TR
Full text How to cite this article

Language: Spanish
References: 25
Page: 92-97
PDF size: 427.79 Kb.


Key words:

fictional characters, porphyrias, vampirism, hypertrichosis, werewolf, Proteus, elephant man.

ABSTRACT

Storytelling has had a great impact for generations in all age groups. The representation of fictional characters are used with the aim of awakening various emotions such as fear, courage, or strength. Through the eyes of a dermatologist, these characterizations can open up a wide range of diagnostic possibilities, but when viewed through the eyes of the non-medical personnel, they can have a significant negative impact on self-esteem and emotional health of those suffering from diseases that are considered as “rare” by society, and portrayed for entertainment or mockery purposes; all of this as a consequence of mythification and ignorance.
Thus, we briefly try to describe the most relevant phenotypic traits of three classic fictional characters that have inspired countless stories: the vampire, the werewolf and the elephant man. Characters that were not really created, but are a modified portrait of real people with stigmatizing and unusual conditions.


REFERENCES

  1. Phillips JD y Anderson KE, The porphyrias. En Kaushansky K, Lichtman MA, Prchal JT et al., Williams hematology, 9ª ed., Nueva York, Mc- Graw-Hill, 2016, pp. 889-914.

  2. Lee WH, Tai WC y Wu PY, Congenital erythropoietic porphyria, Dermatology Sinica 2012; 30(2):62-5. Disponible en: http://dx.doi.org/ 10.1016/j.dsi.2011.09.012.

  3. Katugampola R, Badminton M, Finlay A, Wheatley S, Woolf J, Mason N et al., Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases, British Journal of Dermatology 2012; 167(4):901-13. Disponible en: https://doi.org10.1111j.1365-2133.2012.11160.x [PMID: 22816431].

  4. Guerra TA, Brunete LC, Cabrera DM, Sánchez AR y Vico AC, Porfirias y vampirismo, Más Dermatología 2014; (22)16–21. Disponible en: https://doi.org/10.5538/1887-5181.2014.22.16.

  5. Alves N, Oliveira, RJ y Figuereido DF, Displasia ectodérmica hipohidrótica: un síndrome de interés para la odontología, International Journal of Odontostomatology 2012; 6(1):45–50. Disponible en: http://dx.doi. org/10.4067/S0718-381X2012000100006.

  6. Etimología de licántropo. Disponible en: http://etimologias.dechile. net/?lica.ntropo. Consultado: 7 de septiembre de 2020.

  7. Asz SD, Salas AJ, Beirana PA y Arenas GR, Hipertricosis: sus causas, formas clínicas y manejo, Dermatología cmq 2011; 9(1):33-42. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2011/ dcm111i.pdf.

  8. Reddy KV, Naik MK, Kesidi S y Moni T, Ambras syndrome with gingival hyperplasia: a rare entity, International Journal of Trichology 2016; 8(2),81-83. Disponible en: http://doi.org/10.4103/0974-7753.188036.

  9. Aridjis SE, Chuy, El hombre lobo, México, Producciones Noche Oscura, Cinépolis Producciones, Imcine, 2014; 93. Disponible en: http:// www.imcine.gob.mx/wpcontent/uploads/2019/04/CINEMA_MEXICO_ 2014.pdf.

  10. Olsen EA, Hypertrichosis. En Olsen EA (ed.), Disorders of hair growth: diagnosis and treatment, Nueva York, McGraw-Hill, 1993, pp. 315-36.

  11. Camacho MF, Hypertrichosis. En Blume PU, Tosti A, Whiting DA y Trueb R, Hair growth and disorders, Berlín, Springer, 2008, pp. 334-5.

  12. Hassan SI, Zeerak S, Sajad P, Bashir S, Bhat YJ y Mubashir S, Congenital hypertrichosis lanuginose, Indian Journal of Dermatology, Venereology and Leprology 2018; 84(2):248. doi.org/10.4103/ijdvl.IJDVL_525_16.

  13. Orphanet, Congenital generalized hypertrichosis, Ambras type, inserm. Disponible en: https://www.orpha.net/consor/cgi-bin/OC_Exp. php?lng=EN&Expert=1023#:~:text=Congenital%20generalized%20 hypertrichosis%2C%20Ambras%20type%20is%20an%20extremely% 20rare%20type,of%20palms%2C%20soles%2C%20and%20 mucous. Consultado: 2 de septiembre de 2020.

  14. Rodó JE, Motivos de Proteo (1909), México, Porrúa, 2007. Texto en Wikisource.

  15. Ortega E, García CJ, Martínez MF, Martos MD y Dorantes JA, El síndrome de Proteus, del mundo griego a la medicina, El Peu 2008; 28(3):132-5. Disponible en: https://dialnet.unirioja.es/servlet/articulo?- codigo=2763000.

  16. Caux F, Plauchu H, Chibon F, Faivre L, Fain O, Vabres P et al., Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (solamen) syndrome is related to mosaic pten nullizygosity, European Journal of Human Genetics 2007; 15(7):767-73. doi.org/10.1038/ sj.ejhg.5201823.

  17. Happle R, Type 2 segmental Cowden disease vs. Proteus syndrome, British Journal of Dermatology 2007; 156(5):1089-90. doi.org/10.1111/ j.1365-2133.2007.07818.x.

  18. Ou M, Sun Z, Zhu P, Sun G y Dai Y, Proteus syndrome: a case report and review of the literature, Molecular and Clinical Oncology 2017; 6(3):381-3. doi.org/10.3892/mco.2017.1140

  19. Turner TJ, Cohen JM y Biesecker LG, Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases, American Journal of Medical Genetics 2004; 130A(2): 111-22. doi. org/10.1002/ajmg.a.30327.

  20. Barry M, Proteus Syndrome, Medscape 2018. Recuperado el 1 de septiembre de 2020 de https://emedicine.medscape.com/article/ 948174-overview.

  21. Andrade SL, Nogueira RA, Rosado DI y Pedreira DV, Do you know this syndrome? Anais Brasileiros de Dermatologia 2013; 88(3):473-5. doi. org/10.1590/abd1806-4841.20131965.

  22. Hanssen AM, Werquin H, Suys E y Fryns JP, Cowden syndrome: report of a large family with macrocephaly and increased severity of signs in subsequent generations, Clinical Genetics 2008; 44(6):281-6. doi. org/10.1111/j.1399-0004.1993.tb03901.x.

  23. Biesecker LG, Hallple R, Mulliken JB, Weksberg R, Graham J, Viljoen D et al., Proteus Syndrome: diagnostic criteria, differential diagnosis, and patient evaluation, American Journal of Medical Genetics 1999; 84(5):389- 95. doi.org/10.1002/(SICI)1096-8628(19990611)84:53.0.CO;2-O.

  24. Croley JA, Reese V y Wagner RF, Dermatologic features of classic movie villains: the face of evil, jama Dermatol 2017; 153(6):559-64. doi. org/10.1001/jamadermatol.2016.5979.

  25. Haining RG, Cowger ML Shurtleff DB y Labbe RF, Congenital erythropoietic porphyria, The American Journal of Medicine 1968; 45(4):624-37. doi:10.1016/0002-9343(68)90177-0.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2021;19